C25.3

HCC Category Mapping

What This Code Means

Cancer that originates in the pancreatic duct, the tube that carries digestive enzymes from the pancreas to the small intestine.

Coding Tips

• •Pancreatic duct cancers are typically adenocarcinomas and represent the majority of pancreatic cancers
• •Specify the location within the duct (head, body, or tail) if documented for more precise coding

Clinical Significance

Pancreatic duct adenocarcinoma is the most common and lethal form of pancreatic cancer, with a five-year survival rate under 12%. This code carries significant risk adjustment weight because patients require aggressive multimodal treatment including surgery, chemotherapy, and ongoing supportive care. Accurate capture is critical as these patients consume substantial healthcare resources.

Documentation Requirements

• ✓Pathology-confirmed malignancy with histological type (adenocarcinoma, mucinous, etc.)
• ✓Specific anatomical location within the pancreatic duct documented by imaging or surgical findings
• ✓Current treatment status (active treatment, surveillance, or palliative care)
• ✓Stage at diagnosis (TNM staging preferred)
• ✓Provider assessment confirming active malignancy vs. history of cancer

Commonly Confused Codes